Assuntos
Eritema Nodoso/patologia , Papulose Linfomatoide/patologia , Neoplasias Cutâneas/patologia , Adulto , Biópsia por Agulha , Diagnóstico Diferencial , Feminino , Humanos , Imuno-Histoquímica , Papulose Linfomatoide/terapia , Neoplasias Cutâneas/terapia , Úlcera Cutânea/patologia , Úlcera Cutânea/fisiopatologiaAssuntos
Dermatite/patologia , Papulose Linfomatoide/patologia , Neoplasias Cutâneas/patologia , Úlcera Cutânea/patologia , Adulto , Biópsia por Agulha , Terapia Combinada , Dermatite/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Imuno-Histoquímica , Papulose Linfomatoide/fisiopatologia , Papulose Linfomatoide/terapia , Prognóstico , Neoplasias Cutâneas/fisiopatologia , Neoplasias Cutâneas/terapiaRESUMO
Eccrine poromas are rare, benign adnexal tumors that often occur as solitary papules. Rarely, eccrine poromas can present as multiple lesions, which is referred to as eccrine poromatosis. We report a case of eccrine poromatosis occuring on the palms and soles occuring after chemotherapy in a patient with a history of acute myeloid leukemia.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Leucemia Mieloide Aguda/complicações , Poroma/etiologia , Poroma/patologia , Neoplasias das Glândulas Sudoríparas/complicações , Citarabina/administração & dosagem , Daunorrubicina/administração & dosagem , Etoposídeo/administração & dosagem , Humanos , Leucemia Mieloide Aguda/terapia , Masculino , Pessoa de Meia-Idade , Transplante de Células-Tronco , Neoplasias das Glândulas Sudoríparas/patologiaRESUMO
Morphea is a localized form of scleroderma usually unaccompanied by the typical systemic stigmata that characterize progressive systemic scleroderma. It rarely manifests at the site of whole breast external-beam radiation therapy. We present an unusual case of radiation-induced morphea (RIM) that occurred after accelerated partial breast irradiation (APBI) using intracavitary Contura brachytherapy. A 65-year-old white woman was treated for stage IIA invasive ductal carcinoma of the left breast with APBI to a dose of 34 Gy in 3.4-Gy fractions twice daily over the course 5 days with intracavitary brachytherapy. At 1.5 years after completion of APBI, the patient developed an area of tenderness, erythema, and induration at the site of irradiation. A skin biopsy was consistent with morphea. To our knowledge, this is the first case of RIM confined to the area of APBI.